[1]
2026. PLA2R-positive membranous nephropathy treated with rituximab (MENTOR regimen) in a patient with concomitant endometrial carcinoma: A case report. Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante. 14, 3S (Jul. 2026), 57–58. DOI:https://doi.org/10.56867/.